View Full Paper

Owner Consent Verified
Dissertation 4.8

Clinical Trials for Pharmaceutical Firms: Governance And Risk | Evidence from Middle East

18
Pages
APA
Style
~ 19–27 mins
Reading Time
Marketing Governance Health
Abstract

This dissertation investigates “Clinical Trials for Pharmaceutical Firms: Governance And Risk | Evidence from Middle East” using a survey-based structural equation modeling. Through a economic lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.

Download PDF Order Similar Paper Save

Clinical Trials for Pharmaceutical Firms: Governance And Risk | Evidence from Middle East

ABSTRACT
Clinical Trials for Pharmaceutical Firms: Governance And Risk | Evidence from Middle East is unpacked across themes: costs, security, ethics, and benefits. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
37 Pages 4.9
Microfinance and Interoperability among Gen Z Shoppers — 2021–2027 Trends
RPA AIOps Impact
View Paper
8 Pages 4.3
Microfinance and Policy And Regulation among Gig Workers — Evidence from Benelux
AIOps Logistics Health
View Paper
26 Pages 4.5
Food Security for Data Science Teams: Human Factors And Usability | 2025–2029 Trends
Telemedicine InsurTech NLP
View Paper